Tsukasa Ikeura Selected Research

Autoimmune Pancreatitis

1/2024	Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.
10/2023	Long-term Outcomes after Steroid Pulse Therapy in Patients with Type 1 Autoimmune Pancreatitis.
5/2023	Steroid therapy has an acceptable role as the initial treatment in autoimmune pancreatitis patients with pancreatic cyst formation: Based on a Japanese nationwide study.
4/2023	A case of type 2 autoimmune pancreatitis with spontaneous remission.
3/2023	Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease.
10/2021	The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.
4/2021	Serum free light chain assessment in type 1 autoimmune pancreatitis.
8/2020	Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
7/2020	Efficacy and limitations of the histological diagnosis of type 1 autoimmune pancreatitis with endoscopic ultrasound-guided fine needle biopsy with large tissue amounts.
4/2020	Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsukasa Ikeura Research Topics

Disease

23	Autoimmune Pancreatitis 01/2024 - 01/2007
14	Pancreatitis 11/2023 - 09/2007
13	Neoplasms (Cancer) 01/2024 - 01/2010
7	Immunoglobulin G4-Related Disease 03/2023 - 10/2011
7	Fibrosis (Cirrhosis) 10/2020 - 09/2007
7	Chronic Pancreatitis 08/2020 - 10/2011
6	Adenocarcinoma 06/2023 - 06/2013
6	Pathologic Constriction (Stenosis) 11/2022 - 01/2007
4	Neoplasm Metastasis (Metastasis) 12/2023 - 03/2022
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 09/2014
3	Cholangitis 12/2020 - 03/2013
3	Sclerosing Cholangitis 04/2018 - 01/2010
2	Cysts 03/2024 - 05/2023
2	Diabetes Mellitus 01/2024 - 04/2018
2	Jaundice (Icterus) 04/2018 - 08/2013
2	Disease Progression 04/2018 - 05/2011
2	Infections 04/2017 - 01/2017
2	Lymphadenopathy 01/2016 - 01/2015
2	Hypersensitivity (Allergy) 05/2014 - 10/2011
2	Pain (Aches) 01/2014 - 09/2007
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 10/2011
1	Abscess 03/2024
1	Subphrenic Abscess (Subdiaphragmatic Abscess) 03/2024
1	Ovarian Neoplasms (Ovarian Cancer) 03/2024
1	Osteoporosis 01/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023
1	Carcinoma (Carcinomatosis) 06/2023
1	Varicose Veins (Varicose Vein) 05/2023
1	Pancreatic Cyst 05/2023
1	Neoplasms, Cystic, Mucinous, and Serous 11/2022
1	Lymphatic Metastasis 06/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colitis 01/2021
1	Acute Cholecystitis 12/2020
1	Cholelithiasis 04/2020
1	Splenomegaly 01/2020

Drug/Important Bio-Agent (IBA)

15	SteroidsIBA 01/2024 - 01/2007
12	Immunoglobulin G (IgG)IBA 04/2021 - 01/2010
5	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 05/2011
3	AcidsIBA 06/2020 - 01/2015
2	EnzymesIBA 11/2023 - 01/2020
2	Prednisolone (Predate)FDA LinkGeneric 10/2023 - 05/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2023 - 01/2015
2	CarbohydratesIBA 01/2023 - 02/2022
2	Azathioprine (Imuran)FDA LinkGeneric 10/2021 - 07/2008
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2021
2	Threonine (L-Threonine)FDA Link 01/2021 - 01/2021
2	CytokinesIBA 08/2020 - 04/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
2	Immunoglobulin E (IgE)IBA 05/2014 - 10/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	Amylases FDA Link 11/2023
1	Lipase (Acid Lipase)FDA Link 11/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	Culture MediaIBA 11/2023
1	Methylprednisolone FDA LinkGeneric 10/2023
1	Fluorouracil (Carac)FDA LinkGeneric 05/2023
1	Leucovorin (Folinic Acid)FDA Link 05/2023
1	AntigensIBA 03/2023
1	Rituximab (Mabthera)FDA Link 03/2023
1	GlucocorticoidsIBA 03/2023
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2022
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2022
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Diclofenac (SR 38)FDA LinkGeneric 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	AzoxymethaneIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	CateninsIBA 01/2021
1	CollagenIBA 10/2020
1	Interleukin-27 (Interleukin 27)IBA 08/2020
1	Interleukin-12 Subunit p35IBA 08/2020
1	PorphyrinsIBA 06/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	CalciumIBA 01/2020
1	InterleukinsIBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 01/2020
1	CeruletideIBA 01/2020
1	Capsules (Microcapsules)IBA 09/2019
1	RNA (Ribonucleic Acid)IBA 04/2019

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2007
6	Drug Therapy (Chemotherapy) 12/2023 - 01/2015
4	Laparotomy 03/2024 - 03/2022
3	Stents 06/2021 - 04/2018
2	Neoadjuvant Therapy 12/2023 - 06/2023
2	Pancreatectomy 11/2022 - 01/2010
2	Self Expandable Metallic Stents 06/2021 - 12/2020
2	Enteral Nutrition (Feeding, Tube) 01/2021 - 04/2020
1	Cytoreduction Surgical Procedures 03/2024
1	Intravenous Injections 11/2023
1	Remission Induction 10/2023
1	Secondary Prevention 10/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2023
1	Jejunostomy 11/2022
1	Pancreaticoduodenectomy 11/2022
1	Adjuvant Chemotherapy 06/2022
1	Surgical Instruments (Clip) 11/2021
1	Resuscitation 05/2019